BioSpace News Archive

Drug Development

Dupixent Clears Phase III in Bid to Become First Biologic for COPD

Sanofi and Regeneron’s Dupixent (dupilumab) met its primary and all secondary endpoints in the Phase III BOREAS trial, significantly reducing severe exacerbations in COPD.

March 23, 2023
·
2 min read
·
Tristan Manalac
FDA

Cidara and Melinta Win FDA Approval for First New Echinocandin in a Decade

Wednesday, the FDA approved Cidara Therapeutics and Melinta Therapeutics’ Rezzayo (rezafungin) injection to treat candidemia and invasive candidiasis.

March 23, 2023
·
2 min read
·
Kate Goodwin
Career Advice

When Experience Becomes a Barrier: Ageism at Work

Ageism, or discrimination against an individual based on their age, is a common barrier many older individuals face in the workplace. Fortunately, there are steps that can be taken to mitigate this discrimination.

March 23, 2023
·
4 min read
·
Rosemary Scott
Novo Nordisk Inks Deal with Dewpoint Therapeutics to Boost Diabetes Portfolio

Novo Nordisk and Dewpoint Therapeutics have inked a deal to use the latter’s biomolecular condensates discovery platform to treat insulin resistance and diabetic complications.

March 23, 2023
·
1 min read
·
Ana Mulero
Drug Development

FDA Adcomm Backs Accelerated Approval of Biogen’s Tofersen in SOD1-ALS

The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted 9-0 that tofersen’s effect on neurofilament light chain (NfL) could be a reasonable predictor of clinical benefit.

March 23, 2023
·
2 min read
·
Tristan Manalac
Kiora Pharmaceuticals Reports 2022 Financial Results; Provides Update on Clinical Development Progress

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) today is providing a business update and reporting financial results for the year ended December 31, 2022.

March 23, 2023
·
10 min read
Pharm Country

Vaccinex, Inc. to Present at the 2023 AAIC Advancements: Immunity ConferenceMarch 24th presentation to highlight learnings related to pepinemab’s mechanism of action in both Huntington’s Disease and Alzheimer’s Disease

Vaccinex, Inc. today announced its COO and Senior Vice President, Discovery and Translational Medicine, Elizabeth Evans, PhD, will be making a podium presentation at the AAIC Advancements: Immunity conference.

March 23, 2023
·
4 min read
Biotech Beach

Nexcella Announces New Positive NXC-201 Clinical Data Demonstrating 100% Complete Responses in AL Amyloidosis Patients

Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”) today announced that NXC-201 treatment continues to demonstrate 100% complete hematologic responses and 100% organ response rate.

March 23, 2023
·
8 min read
Business

Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial Results

Aeterna Zentaris Inc. today reported its financial and operating results for the year ended December 31, 2022.

March 23, 2023
·
8 min read
Drug Development

electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury

electroCore, Inc. today announced the publication of a paper entitled “Non-Invasive Vagus Nerve Stimulation Improves Brain Lesion Volume and Neurobehavioral Outcomes in a Rat Model of Traumatic Brain Injury” in the peer-reviewed Journal of Neurotrauma.

March 23, 2023
·
7 min read